ELBION AG
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 02, 2008 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 163 Total Citation Count
- May 15, 1998 Earliest Filing
- 21 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing themExpiredJan 10, 06Sep 02, 08[A61K]
2007/0299,079 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEMAbandonedMay 24, 07Dec 27, 07[A61K, C07D, A61P]
2007/0093,531 Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themAbandonedNov 30, 06Apr 26, 07[A61K, C07D]
7166637 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themExpiredNov 13, 03Jan 23, 07[A61K]
7161009 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationExpiredFeb 21, 02Jan 09, 07[C07D]
2006/0293,362 Nitro-substituted hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themAbandonedJun 22, 06Dec 28, 06[A61K, C07D]
7122674 Process for preparing high-purity hydroxyindolylglyoxylamidesExpiredJul 31, 03Oct 17, 06[C07D]
7067536 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsExpiredApr 16, 04Jun 27, 06[A61K]
2005/0032,863 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptorAbandonedJun 28, 04Feb 10, 05[A61K]
2004/0266,760 5-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsAbandonedApr 14, 04Dec 30, 04[A61K, C07D]
RE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparationExpiredSep 19, 02Oct 12, 04[A61K, C07D]
2004/0116,501 Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitorsAbandonedSep 03, 03Jun 17, 04[A61K]
2003/0186,997 2,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the sameAbandonedFeb 18, 03Oct 02, 03[A61K, C07D]
6613794 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationExpiredJan 20, 03Sep 02, 03[A61K, C07D]
6602890 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationExpiredFeb 21, 02Aug 05, 03[A61K, C07D]
6545025 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationExpiredFeb 21, 02Apr 08, 03[A61K]
6545158 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationExpiredFeb 21, 02Apr 08, 03[C07D]
6472165 Modulatory binding site in potassium channels for screening and finding new active ingredientsExpiredAug 03, 99Oct 29, 02[C12Q, C12N]
6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicamentsExpiredMay 05, 99Dec 26, 00[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.